STAT3 and cervical cancer: Our patients’ data together with experimental evidence that chronic activation of STAT3 promotes tolerance toward cervical cancer antigens (5, 8) led us to investigate if IL-6 and G-CSF could have a role in tumor growth and modulation of tumor systemic effects.